Business
Press Release Feb 17 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 17, 2023, titled "Zydus receivesfinal approval from the USFDA for Sirolimus Tablets, 1 mg and 2 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 17, 2023, titled \"Zydus receivesfinal approval from the USFDA for Sirolimus Tablets, 1 mg and 2 mg\". View Attachment","length":348,"tagName":"div"}]